The SARS-CoV-2 virus caused Coronavirus Disease 2019 (COVID-19), initially occurred in Wuhan, China.
•
COVID-19 outbreak started in China, resulting in a pandemic in several countries.
•
Up to this point, the Food and Drug Administration (FDA) has only approved one medication for COVID-19 (Remdesivir).
•
A variety of therapy approaches are available to prevent the disease from spreading and to reduce morbidity and mortality.
•
The current article reviews the most up-to-date information about the COVID-19 treatment and/or vaccine’s availability.
Abstract
Coronavirus disease 2019 (COVID-19) is a remarkably contagious and pathogenic viral infection arising from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which first appeared in Wuhan, China. For the time being, COVID-19 is not treated with a specific therapy. The Food and Drug Administration (FDA) has approved Remdesivir as the first drug to treat COVID-19. However, many other therapeutic approaches are being investigated as possible treatments for COVID-19. As part of this review, we discussed the development of various drugs, their mechanism of action, and how they might be applied to different cases of COVID-19 patients. Furthermore, this review highlights an update in the emergence of new prophylactic or therapeutic vaccines against COVID-19. In addition to FDA or The World Health Organization (WHO) approved vaccines, we intended to incorporate the latest published data from phase III trials about different COVID-19 vaccines and provide clinical data released on the networks or peer-review journals.
